{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:51:27Z","timestamp":1789689087820,"version":"4.0.1"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,2,1]]},"DOI":"10.1093\/jac\/dkx390","type":"journal-article","created":{"date-parts":[[2017,9,28]],"date-time":"2017-09-28T07:08:54Z","timestamp":1506582534000},"page":"280-286","source":"Crossref","is-referenced-by-count":30,"title":["A CPAnet consensus statement on research priorities for chronic pulmonary aspergillosis: a neglected fungal infection that requires attention"],"prefix":"10.1093","volume":"73","author":[{"given":"Cendrine","family":"Godet","sequence":"first","affiliation":[{"name":"CHU de Poitiers, Service des Maladies Infectieuses et Tropicales, Poitiers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Alastruey-Izquierdo","sequence":"additional","affiliation":[{"name":"Mycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Flick","sequence":"additional","affiliation":[{"name":"Division of Pulmonology, Department of Internal Medicine, Medical University of Graz, Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Hennequin","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9s, UPMC Universit\u00e9 Paris 06, Inserm UMR S 1135, CNRS ERL 8255, Centre d\u2019Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France"},{"name":"AP-HP, H\u00f4pital Saint-Antoine, Service de Parasitologie-Mycologie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rihards","family":"Mikilps-Mikgelbs","sequence":"additional","affiliation":[{"name":"Centre of TB and Lung Diseases, Riga East University Hospital, Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oxana","family":"Munteanu","sequence":"additional","affiliation":[{"name":"State University of Medicine and Pharmacy \u2018Nicolae Testemitanu\u2019, Department of Internal Medicine, Division of Pneumology and Allergology, Chisinau, Republic of Moldova"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"Page","sequence":"additional","affiliation":[{"name":"National Aspergillosis Centre, University Hospital of South Manchester, Manchester, UK"},{"name":"Division of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danila","family":"Seidel","sequence":"additional","affiliation":[{"name":"Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut J F","family":"Salzer","sequence":"additional","affiliation":[{"name":"Division of Clinical Infectious Diseases and German Centre for Infection Research Tuberculosis Unit, Research Centre Borstel, Borstel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"CPAnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,11,6]]},"reference":[{"key":"key\n\t\t\t\t20180328144135_dkx390-B1","doi-asserted-by":"crossref","first-page":"165rv13.","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci Transl Med"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B2","doi-asserted-by":"crossref","first-page":"864","DOI":"10.2471\/BLT.11.089441","article-title":"Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis","volume":"89","author":"Denning","year":"2011","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1183\/13993003.00583-2015","article-title":"Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management","volume":"47","author":"Denning","year":"2016","journal-title":"Eur Respir J"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/myc.12103","article-title":"Volume dependency for culture of fungi from respiratory secretions and increased sensitivity of Aspergillus quantitative PCR","volume":"57","author":"Fraczek","year":"2014","journal-title":"Mycoses"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B5","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3109\/13693786.2013.806826","article-title":"Clinical characteristics and treatment outcomes of chronic pulmonary aspergillosis","volume":"51","author":"Jhun","year":"2013","journal-title":"Med Mycol"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B6","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jinf.2015.11.003","article-title":"Comparison of six Aspergillus-specific IgG assays for the diagnosis of chronic pulmonary aspergillosis (CPA)","volume":"72","author":"Page","year":"2016","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B7","doi-asserted-by":"crossref","first-page":"E197","DOI":"10.1111\/1469-0691.12133","article-title":"Performance of two Aspergillus IgG EIA assays compared with the precipitin test in chronic and allergic aspergillosis","volume":"19","author":"Baxter","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/mmy\/myv020","article-title":"Antibody testing in aspergillosis\u2014quo vadis?","volume":"53","author":"Page","year":"2015","journal-title":"Med Mycol"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B9","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1128\/JCM.03261-15","article-title":"Prospective evaluation of a new Aspergillus IgG enzyme immunoassay kit for diagnosis of chronic and allergic pulmonary aspergillosis","volume":"54","author":"Dumollard","year":"2016","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B10","first-page":"2712","article-title":"Clinico-microbiological profile of chronic pulmonary aspergillosis from a tertiary care centre in southern India","volume":"7","author":"Chawla","year":"2013","journal-title":"J Clin Diagn Res"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B11","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s10096-015-2409-7","article-title":"Prevalence of chronic pulmonary aspergillosis in patients with tuberculosis from Iran","volume":"34","author":"Hedayati","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B12","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1007\/s10096-012-1690-y","article-title":"Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial","volume":"31","author":"Cadranel","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B13","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1055\/s-0031-1295716","article-title":"Allergic bronchopulmonary aspergillosis and related allergic syndromes","volume":"32","author":"Hogan","year":"2011","journal-title":"Semin Respir Crit Care Med"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B14","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1086\/657306","article-title":"Efficacy and safety of posaconazole for chronic pulmonary aspergillosis","volume":"51","author":"Felton","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B15","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01062-2016","article-title":"Predictors of mortality in chronic pulmonary aspergillosis","volume":"49","author":"Lowes","year":"2017","journal-title":"Eur Respir J"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.chest.2016.02.640","article-title":"CT imaging assessment of response to treatment in chronic pulmonary aspergillosis","volume":"150","author":"Godet","year":"2016","journal-title":"Chest"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B17","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B18","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/myc.12075","article-title":"Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature","volume":"56","author":"Agarwal","year":"2013","journal-title":"Mycoses"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/crj.12105","article-title":"Characteristics and outcomes of chronic pulmonary aspergillosis: a retrospective analysis of a tertiary hospital registry","volume":"9","author":"Camara","year":"2015","journal-title":"Clin Respir J"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B20","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1378\/chest.06-2441","article-title":"Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients","volume":"131","author":"Camuset","year":"2007","journal-title":"Chest"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B21","doi-asserted-by":"crossref","first-page":"e37.","DOI":"10.1038\/emi.2016.31","article-title":"A 10-year study reveals clinical and laboratory evidence for the \u2032semi-invasive\u2032 properties of chronic pulmonary aspergillosis","volume":"5","author":"Chan","year":"2016","journal-title":"Emerg Microbes Infect"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s15010-014-0711-4","article-title":"Treatment of chronic pulmonary aspergillosis with voriconazole: review of a case series","volume":"43","author":"Cucchetto","year":"2015","journal-title":"Infection"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B23","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jinf.2010.08.005","article-title":"Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: a multicenter trial in Japan","volume":"61","author":"Kohno","year":"2010","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B24","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.medmal.2015.01.014","article-title":"Chronic pulmonary aspergillosis: a frequent and potentially severe disease","volume":"45","author":"Benjelloun","year":"2015","journal-title":"Med Mal Infect"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B25","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.resinv.2015.08.007","article-title":"Clinical characteristics of patients with Aspergillus species isolation from respiratory samples: comparison of chronic pulmonary aspergillosis and colonization","volume":"54","author":"Ohara","year":"2016","journal-title":"Respir Investig"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B26","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jinf.2014.01.005","article-title":"Serum galactomannan antigen test for the diagnosis of chronic pulmonary aspergillosis","volume":"68","author":"Shin","year":"2014","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B27","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.rmed.2012.01.014","article-title":"Clinical characteristics and prognosis of chronic pulmonary aspergillosis","volume":"106","author":"Ohba","year":"2012","journal-title":"Respir Med"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B28","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s15010-012-0322-x","article-title":"Efficacy and safety of voriconazole in the treatment of chronic pulmonary aspergillosis: experience in Japan","volume":"40","author":"Saito","year":"2012","journal-title":"Infection"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B29","doi-asserted-by":"crossref","first-page":"527. e17","DOI":"10.1016\/j.amjmed.2005.11.028","article-title":"Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis","volume":"119","author":"Sambatakou","year":"2006","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jiac.2014.02.003","article-title":"Recurrence of chronic pulmonary aspergillosis after discontinuation of maintenance treatment by antifungal triazoles","volume":"20","author":"Koyama","year":"2014","journal-title":"J Infect Chemother"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B31","doi-asserted-by":"crossref","first-page":"e0168373.","DOI":"10.1371\/journal.pone.0168373","article-title":"Outcomes of bronchial artery embolization for life-threatening hemoptysis in patients with chronic pulmonary aspergillosis","volume":"11","author":"Shin","year":"2016","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B32","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1128\/JCM.02497-16","article-title":"Usefulness of two Aspergillus PCR assays and Aspergillus galactomannan and \u03b2-d-glucan testing of bronchoalveolar lavage fluid for diagnosis of chronic pulmonary aspergillosis","volume":"55","author":"Urabe","year":"2017","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B33","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/thx.46.11.839","article-title":"Treatment of pulmonary aspergilloma with itraconazole","volume":"46","author":"Campbell","year":"1991","journal-title":"Thorax"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B34","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1439-0507.1988.tb03653.x","article-title":"The treatment of aspergillosis and aspergilloma with itraconazole, clinical results of an open international study (1982-1987)","volume":"31","author":"De Beule","year":"1988","journal-title":"Mycoses"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B35","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1086\/376526","article-title":"Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review","volume":"37","author":"Denning","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B36","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0190-9622(90)70263-H","article-title":"Itraconazole therapy in aspergillosis: study in 49 patients","volume":"23","author":"Dupont","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B37","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s10156-012-0391-x","article-title":"The clinical efficacy and safety of micafungin-itraconazole combination therapy in patients with pulmonary aspergilloma","volume":"18","author":"Fujita","year":"2012","journal-title":"J Infect Chemother"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B38","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/13693780701278386","article-title":"Clinical efficacy of micafungin for chronic pulmonary aspergillosis","volume":"45","author":"Izumikawa","year":"2007","journal-title":"Med Mycol"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B39","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1016\/j.jinf.2005.08.022","article-title":"The efficacy and tolerability of voriconazole in the treatment of chronic cavitary pulmonary aspergillosis","volume":"52","author":"Jain","year":"2006","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B40","doi-asserted-by":"crossref","first-page":"e479","DOI":"10.1016\/j.ijid.2009.07.011","article-title":"Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases","volume":"14","author":"Nam","year":"2010","journal-title":"Int J Infect Dis"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B41","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1378\/chest.112.2.541","article-title":"Chronic necrotizing pulmonary aspergillosis: approach to management","volume":"112","author":"Saraceno","year":"1997","journal-title":"Chest"},{"key":"key\n\t\t\t\t20180328144135_dkx390-B42","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s10156-012-0414-7","article-title":"Efficacy and safety of short- and long-term treatment of itraconazole on chronic necrotizing pulmonary aspergillosis in multicenter study","volume":"18","author":"Yoshida","year":"2012","journal-title":"J Infect Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/73\/2\/280\/23610178\/dkx390.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T16:45:13Z","timestamp":1522255513000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/73\/2\/280\/4596637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,6]]},"references-count":42,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,11,6]]},"published-print":{"date-parts":[[2018,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkx390","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,2]]},"published":{"date-parts":[[2017,11,6]]}}}